
Rahika
- Strength
- 150mg/200mg
- Manufacturer
- Novartis Pharma
- Availability
- Available to source
Ask for price
Capmatinib 150mg/200mg — Tablet, 60's Strip
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
Rahika uses and dosage
Rahika (Capmatinib) is a prescription medicine used to treat metastatic non-small cell lung cancer (NSCLC). Capmatinib works by slowing or stopping the growth of cancer cells. Rahika manufactured by NOVARTIS. Capmatinib has to take orally twice daily with or without food.
Indications
Lung cancer
Rahika side effects
The most common side effects of Capmatinib are: Swelling hands/ankles/feet, tiredness, fever, nausea / vomiting, decreased appetite, weight loss, constipation, or diarrhea.
- Originator brand
- Tabrecta by NOVARTIS
- Made by
- Novartis Pharma
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.



